SUN PHARMA CANADA INC — Ramipril Importer Profile
Pharmaceutical Importer · #19 buyer for Ramipril · $1.8M import value · 135 shipments · CANADA · DGFT Verified
SUN PHARMA CANADA INC is the #19 importer of Ramipril from India with $1.8M in import value and 135 verified shipments. SUN PHARMA CANADA INC holds a 1.1% market share in Ramipril imports based in CANADA. The company sources from 1 verified supplier across 76 formulations shipped to 1 country. Overall, SUN PHARMA CANADA INC imports 8 pharmaceutical products worth $8.7M across 5 therapeutic categories.
SUN PHARMA CANADA INC — Ramipril Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ramipril to SUN PHARMA CANADA INC?
Verified from 135 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.8M | 135 | 100.0% |
SUN PHARMA CANADA INC sources Ramipril from 1 verified Indian supplier based on 135 customs records. The primary supplier is SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 100.0% of imports.
Where Does SUN PHARMA CANADA INC Import Ramipril To?
Destination countries from 135 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $1.8M | 135 | 100.0% |
SUN PHARMA CANADA INC imports Ramipril to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $1.8M.
What Ramipril Formulations Does SUN PHARMA CANADA INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS | $367.8K | 14 |
| RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS5+12.5MG (TARO RAMIPRIL+HCTZ TAB 5+12.5MG)EACH TABLETCONTIANS**NOS | $73.8K | 6 |
| RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS10 12 5MG TARO RAMIPRIL HCTZ RXY TAB 10 12 5MG PACK 100s Bottl Batch PTD5 | $53.6K | 2 |
| RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS10+12.5MG (TARO-RAMIPRIL+HCTZ RXY TAB 10+12.5MG) EACH TABLET CONTAINS: **** | $53.3K | 3 |
| HSN CODE:30049071 SAP CODE:1117536 TARO-RAMIPRIL HCTZ TAB 10/12.5MG 100 BTL (RAMIPRIL & HCTZ TAB LETS) PACK : 100S BOTTL | $50.0K | 1 |
| TARO RAMIPRIL HCTZ TABLETS 5 12 5MG RAMIPRIL HYDROCHLOROTHIAZIDE TABLETS 5 12 5MG 5160 PACK X 100 S BOTTLES BATCH | $50.0K | 1 |
| RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS10+12.5MG (TARO RAMIPRIL+HCTZ TAB 10+12.5MG)EACH TABLETCONTIANS**NOS | $44.7K | 6 |
| TARO RAMIPRIL CAP 10 MG PACK 500sBottle Batch PTD3461B PTD3462B PTD3463B PTD3464C EACH CAP CONTS RAMIPRIL BP Ph Eu | $39.6K | 1 |
| TARO-RAMIPRIL CAP 10 MG EACH CAPSULE CON | $38.7K | 2 |
| RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS5+12.5MG TARO RAMIPRIL+ HCTZ TAB 5+12.5MG B/NO AS PER ATTACHED DOCUMENT | $37.0K | 1 |
SUN PHARMA CANADA INC imports 76 distinct Ramipril formulations from India. The top formulation is RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS with 14 shipments worth $367.8K.
Regulatory Requirements: Importing Ramipril into Canada
What SUN PHARMA CANADA INC and other importers must comply with to import Ramipril from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Ramipril
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ramipril from India and How Much Does SUN PHARMA CANADA INC Import?
India exported $39.7M worth of Ramipril through 4,977 shipments from 177 suppliers to 93 countries, serving 389 buyers globally. SUN PHARMA CANADA INC imports $1.8M of this total, accounting for 1.1% of India's Ramipril exports with 135 shipments from CANADA. This is verified from 135 customs shipment records covering 76 distinct formulations.
What Is the Average Order Value for SUN PHARMA CANADA INC's Ramipril Imports?
SUN PHARMA CANADA INC's average Ramipril order value is $13.3K per consignment, based on 135 shipments totaling $1.8M. SUN PHARMA CANADA INC is based in CANADA and ranks #19 among all Ramipril importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ramipril to SUN PHARMA CANADA INC?
SUN PHARMA CANADA INC sources Ramipril from 1 verified Indian supplier: SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.8M, 100.0%). This is based on 135 customs records.
How Does SUN PHARMA CANADA INC Compare to Other Ramipril Importers?
SUN PHARMA CANADA INC ranks #19 among 389 Ramipril importers from India with a 1.1% market share. The top 3 importers are WOCKHARDT UK LIMITED ($6.7M), CRESCENT PHARMA LTD ($5.8M), BROWN AND BURK UK LIMITED ($4.0M). SUN PHARMA CANADA INC processed 135 shipments from CANADA.
What Other Cardiovascular Products Does SUN PHARMA CANADA INC Import?
SUN PHARMA CANADA INC also imports these cardiovascular products. Each links to the detailed product page.
About SUN PHARMA CANADA INC
SUN PHARMA CANADA INC imports 8 products worth $8.7M. Beyond Ramipril, top products include Esomeprazole, Magnesium, Gliclazide, Omeprazole, Sunitinib. View the complete SUN PHARMA CANADA INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ramipril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ramipril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SUN PHARMA CANADA INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SUN PHARMA CANADA INC's capped import value divided by total capped export value for Ramipril across all Indian exporters.
- 5.Verified Records: This page is backed by 135 individual customs records matching SUN PHARMA CANADA INC importing Ramipril, covering 76 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 93+ countries, 389+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ramipril Import Data for SUN PHARMA CANADA INC
Access order-level details, pricing data, supplier connections, and competitive analysis for SUN PHARMA CANADA INC's Ramipril imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN PHARMA CANADA INC
Full Company Profile →
8 products · $8.7M total trade · 5 categories
SUN PHARMA CANADA INC × Ramipril
Verified from customs records
Company Overview
Top Products by SUN PHARMA CANADA INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SUN PHARMA CANADA INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ramipril. For current order-level data, contact TransData Nexus.